Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.136 USD | -8.42% | -23.51% | -89.85% |
May. 15 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
Business Summary
Number of employees: 80
Managers
Managers | Title | Age | Since |
---|---|---|---|
Manuel Litchman
CEO | Chief Executive Officer | 70 | 17-04-23 |
James Murphy
DFI | Director of Finance/CFO | 67 | Jan. 18 |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Greg Furrow
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Bruce Dezube
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Peter Carney
AUD | Comptroller/Controller/Auditor | 38 | 21-07-31 |
Robert Sexton
PRN | Corporate Officer/Principal | - | 22-09-30 |
Rick Bodmer
PRN | Corporate Officer/Principal | - | 22-07-31 |
Lynn E. Bayless
LAW | General Counsel | - | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 15-03-12 | |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 15-07-31 |
Adam Chill
BRD | Director/Board Member | 56 | 17-06-06 |
Manuel Litchman
CEO | Chief Executive Officer | 70 | 17-04-23 |
Michael Zelefsky
BRD | Director/Board Member | 63 | 17-06-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 845,385 | 0 | 0 | 75.89 % |
Stock B | 1 | 11,669,505 | 9,497,789 ( 81.39 %) | 0 | |
Stock C | 0 | 250,000 | 0 | 0 |
Company contact information
Mustang Bio, Inc.
377 Plantation Street 1st floor
01605-2245, Worcester
+781 652 4500
http://www.mustangbio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.85% | 4.18M | |
+18.73% | 125B | |
+13.69% | 108B | |
-7.30% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-14.10% | 16.37B | |
+2.37% | 13.58B | |
+27.88% | 11.66B |
- Stock Market
- Equities
- MBIO Stock
- Company Mustang Bio, Inc.